Cc1ccc(-n2c(SCc3cccc(F)c3)nc3[nH]ncc3c2=O)cc1C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?